Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant
Pseudomonas aeruginosa
bronchiectasis
ceftolozane/tazobactam
continuous infusion
outpatient parenteral antimicrobial therapy
therapeutic drug monitoring
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
21 Jul 2023
21 Jul 2023
Historique:
received:
19
06
2023
revised:
17
07
2023
accepted:
18
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
(1) Background: Ceftolozane/tazobactam (C/T) is a novel β-lactam/β-lactamase inhibitor with excellent activity against the multidrug-resistant (MDR)
Identifiants
pubmed: 37508309
pii: antibiotics12071214
doi: 10.3390/antibiotics12071214
pmc: PMC10376517
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
PLoS One. 2014 Jul 14;9(7):e102023
pubmed: 25019523
N Engl J Med. 2022 Aug 11;387(6):533-545
pubmed: 35947710
Curr Ther Res Clin Exp. 2017 Mar 06;84:22-25
pubmed: 28761575
Drugs. 2014 Jan;74(1):31-51
pubmed: 24352909
Respir Med. 2020 Dec 24;177:106285
pubmed: 33401148
Antimicrob Agents Chemother. 2019 May 24;63(6):
pubmed: 30962340
Chest. 2010 Oct;138(4):944-9
pubmed: 20435655
Ann Intern Med. 2021 Jun;174(6):822-827
pubmed: 33819054
Crit Care. 2019 Mar 29;23(1):104
pubmed: 30925922
Antimicrob Agents Chemother. 1991 Jun;35(6):1081-4
pubmed: 1656853
Open Forum Infect Dis. 2020 Jan 12;7(2):ofaa014
pubmed: 32042849
Open Forum Infect Dis. 2023 Mar 28;10(5):ofad173
pubmed: 37180591
Open Forum Infect Dis. 2017 Jun 29;4(2):ofx097
pubmed: 28852672
Chest. 2017 May;151(5):982-992
pubmed: 27889361
Clin Infect Dis. 2014 Apr;58(8):1072-83
pubmed: 24429437
Clin Infect Dis. 2016 Jul 15;63(2):234-41
pubmed: 27098166
Ann Am Thorac Soc. 2015 Dec;12(12):1764-70
pubmed: 26431397
Ann Pharmacother. 2011 Nov;45(11):1329-37
pubmed: 21990938
Open Forum Infect Dis. 2018 Oct 31;5(11):ofy280
pubmed: 30488041
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31871076
Eur Respir J. 2017 Sep 9;50(3):
pubmed: 28889110
Thorax. 2019 Jan;74(Suppl 1):1-69
pubmed: 30545985
Int J Antimicrob Agents. 2020 Nov;56(5):106158
pubmed: 32919007
Drugs. 2023 Jul;83(11):967-983
pubmed: 37314633
J Antimicrob Chemother. 2022 May 29;77(6):1600-1610
pubmed: 35323912
Eur J Hosp Pharm. 2020 Mar;27(2):90-94
pubmed: 32153771
J Antimicrob Chemother. 2017 May 1;72(5):1462-1465
pubmed: 28158637
Eur J Hosp Pharm. 2020 Mar;27(e1):e84-e86
pubmed: 32296512
Semin Respir Crit Care Med. 2021 Aug;42(4):587-594
pubmed: 34261182
Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):355-375
pubmed: 28776441
Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2
pubmed: 9455502
Expert Rev Clin Pharmacol. 2021 May;14(5):583-599
pubmed: 33687300
Ann Am Thorac Soc. 2015 Nov;12(11):1602-11
pubmed: 26356317
Int J Tuberc Lung Dis. 2015 May;19(5):610-9
pubmed: 25868032
J Antimicrob Chemother. 2022 Apr 27;77(5):1481-1490
pubmed: 35187565
BMJ Open. 2021 Sep 28;11(9):e049733
pubmed: 34588251
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28483953
Curr Opin Infect Dis. 2020 Dec;33(6):501-510
pubmed: 33009140